BLCOBausch + Lomb Corporation

1. Aug 12, 2026On August 6, 2026, Bausch + Lomb Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) regarding the resignation of certain members of its board of directors (the “Board”) and the appointment of Thomas J. Appio, Robert Chersi, Laurence Paul, M.D. and Barbara Trebbi to the Board, effective …Director or officer change · Form 8-K/A
2. Aug 6, 2026The information set forth below under.Material agreement entered · Form 8-K
3. Jul 29, 2026Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance.Earnings release · press release
4. Apr 29, 2026Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook.Earnings release · press release
5. Feb 18, 2026Delivered meaningful EBITDA margin expansion and operating leverage in the fourth quarter.Earnings release · press release
6. Jan 2, 2026On January 2, 2026, Bausch + Lomb Corporation (the “Company”) entered into an amendment (the “Fourth Amendment”) to the Credit and Guaranty Agreement, dated as of May 10, 2022 (as amended by the First Incremental Amendment, dated as of September 29, 2023, by the Second Incremental Amendment, dated as of November 1 …Material agreement entered · Form 8-K
7. Dec 22, 2025On December 17, 2025, Bausch + Lomb Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) regarding the appointment of Eduardo C. Alfonso, MD and Steven H. Collis to its board of directors (the “Board”), effective January 1, 2026.Director or officer change · Form 8-K/A
8. Dec 17, 2025On December 17, 2025, Bausch + Lomb Corporation (the “Company”) announced the appointment of Eduardo C. Alfonso, MD and Steven H. Collis to its board of directors (the “Board”), effective January 1, 2026, to fill the vacancies created by the departure of Brett Icahn and Gary Hu from the Board in August 2025.Director or officer change · Form 8-K
9. Dec 12, 2025Credit Agreement Refinancing On December 12, 2025, Bausch + Lomb Corporation (the “Company” or “Bausch + Lomb”) announced that it allocated a $2,802,125,000 tranche (the “Replacement Term Loans”) of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the …Other event · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.